The European Medicines Company'' s Pharmacovigilance Threat Evaluation Board (PRAC) has actually concluded following a testimonial of the readily available proof that the benefits of mixture remedies consisting of hydroxyethyl-starch (HES) no longer exceed their dangers …
See Initial Write-up”
DALLAS, June 17, 2013–/ PRNewswire/– Dr. Chandler George, worldwide recognized advertising authority, chiropractic doctor and also creator of Catchfire Advertising and marketing, introduced that he'' s currently offering a new and also special health club solution for dental practitioners, chiropractic doctors …
See Initial Post”
Most recent study results for social media sites advertising and marketing: find just what methods, tools and methods social networks marketing professionals are using.Social Media Examiner
See Original Post”
Popular Questions
What happened to the marketing authorisations for infusion solutions containing hydroxyethyl-starch?
Marketing authorisations for infusion solutions containing hydroxyethyl-starch were subject to regulatory review because of evidence linking these products to serious kidney injury and mortality risks in some patient groups. European regulators recommended suspension or significant restriction of their use when the risks were judged to outweigh the benefits. The current status should be checked in the relevant national medicines database or regulatory notice.
Why were hydroxyethyl-starch infusion solutions restricted or suspended?
Regulatory authorities identified safety concerns involving renal replacement therapy, kidney injury, bleeding, and increased mortality in critically ill patients. These concerns led to reviews of the benefit-risk balance for products covered by marketing authorisations for infusion solutions containing hydroxyethyl-starch. Restrictions generally focus on preventing use in patients for whom the risks are especially high.
Can hydroxyethyl-starch still be used under a marketing authorisation?
Availability and permitted use depend on the country, the specific product, and the conditions attached to its marketing authorisation. Where authorisations remain valid, use may be limited to carefully selected patients and subject to warnings, monitoring, or controlled-access requirements. Healthcare professionals should consult the current product information and follow national regulatory guidance before prescribing or administering the solution.
How can I verify the status of marketing authorisations for hydroxyethyl-starch infusions?
Search the medicines regulator in the relevant country using the product name, active substance, and marketing authorisation number. Check whether the record shows an active authorisation, suspension, revocation, or restrictions, and review the latest safety communication and product information. Do not rely on an older package leaflet because the regulatory status of hydroxyethyl-starch infusion solutions may have changed.